Profil
Randall L.
Halcomb was the founder of Terns Pharmaceuticals, Inc. (founded in 2017) where he held the title of SVP-Chemistry & Early Development from 2017 to 2019.
He also held former positions as Director-Medicinal Chemistry at Gilead Sciences, Inc., Vice President-Chemistry at Igenica Biotherapeutics, Inc., and Vice President-Medicinal Chemistry at Pliant Therapeutics, Inc. (2016-2017).
Dr. Halcomb received a doctorate degree from Yale University and an undergraduate degree from The University of Alabama.
Tidigare kända positioner av Randall L. Halcomb
| Företag | Position | Slut |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Grundare | 2019-01-01 |
| PLIANT THERAPEUTICS, INC. | Företagsledare/Principal | 2017-01-01 |
| GILEAD SCIENCES, INC. | Företagsledare/Principal | - |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer | Företagsledare/Principal | - |
Randall L. Halcombs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Alabama
The University of Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
















